Sunday, December 06, 2009 3:04:24 PM
Cryoport I got your point. The difference being that if the company announces a deal with revenues vs. agreement to market or whatever that was, we'll attact new investors. Right now we are a company that has generated 9,000 per quarter in revenues. I'm pretty sure that isn't what the market is looking for from the company. Despite its potential, everybody has heard about it, the time for the company will come with the announcement of real significant revenues. Once that happens, it won't really matter if the note holders convert out. The buyers will continue to come as long as they see progress. We've been treading water since the last Fedex news. Let them convert out as much now, so they won't be there to profit later.
Recent CYRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:30:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/10/2025 09:10:52 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2025 07:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 07:33:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 10:18:14 PM
- Cryoport Reports Third Quarter 2025 Financial Results • PR Newswire (US) • 11/04/2025 09:05:00 PM
- Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain • PR Newswire (US) • 10/30/2025 12:30:00 PM
